Project & Team

Clinical Project Description of CMT-MOD Biomarker Study

Recruitment

Patient Recruitment only via E-Mail: 

contact@cmt-mod.org

 

Sponsor

This study is sponsored by the AFMTÉLÉTON.

 

Study Title

Full Title: A multi-omic approach to the identification of novel biomarkers in early Charcot-Marie-Tooth 1A disease (CMT1A) (CMT-MODs)

 

Clinical Phase

This is a biomarker study, not associated with a specific clinical phase.

 

Coordinators

Lead Coordinator:
Univ.-Prof. Dr. med. Michael W. Sereda
University Medical Centre Göttingen (UMG), Department of Neurology
Address: Robert-Koch-Str. 40, 37075 Göttingen, Germany
Email: mwsereda@med.uni-goettingen.de or sereda@mpinat.mpg.de

Co-Coordinator:
Prof. Shahram Attarian, M.D., Ph.D.
Neuromuscular Disease and ALS Reference Center, Timone University Hospital, Aix-Marseille University
Address: CHU Timone, 264 rue Saint Pierre, 13385 Marseille Cedex 05, France
Email: Shahram.ATTARIAN@ap-hm.fr

 

 

Participating Centers

The project involves multiple research centers led by principal investigators, including:

University Medical Centre Göttingen (UMG), Germany

Principal Investigator: Univ.-Prof. Dr. Michael Sereda

Timone University Hospital, Aix-Marseille University, France

Principal Investigator: Prof. Shahram Attarian

 

Research Partners and Collaborators

Research Partners (Direct Funding)

These Institutions are directly involved in the project´s core activities and receive funding to support their work.

 

Collaborating Partners (Indirect funding via P1 or P2)

 

Objectives (primary and secondary)

Estimated Study Duration

Inclusion Period: 6 months

Study Duration: 12 months

Total Timeframe: 18 months (from first patient enrolled to last patient completed).

Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen

Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.